ACUS.PK

[fous]

i love ascending triangles. So i love ACUS. Im buying in the morning.

-fous

[fous]

Presenting at a health conference tomorrow.

WATERTOWN, Mass.--(Business Wire)--March 1, 2006-- Acusphere, Inc. (NASDAQ: ACUS) announced today that Sherri C. Oberg, President and Chief Executive Officer, is scheduled to present at the Cowen & Co. 26th Annual Health Care Conference on Tuesday, March 7, 2006 at 2:20 p.m. Eastern Time. The Conference is being held at The Boston Marriott Copley Place Hotel.

A webcast of the Company's presentation will be available both live and on a recorded basis via a link provided at the company's website www.acusphere.com on the Investor Relations page. The recording will be available through March 21, 2006.

About Acusphere, Inc.

Acusphere (NASDAQ: ACUS) is a specialty pharmaceutical company that develops new drugs and improved formulations of existing drugs using its proprietary microparticle technology. Acusphere's three initial product candidates are designed to address large unmet clinical needs within cardiology, oncology and asthma. These product candidates were created using proprietary technology that enables Acusphere to control the porosity and size of nanoparticles and microparticles in a versatile manner that allows particles to be customized to address the delivery needs of a variety of drugs. Acusphere's lead product candidate, AI-700, is a cardiovascular drug in Phase 3 clinical development. AI-700 is designed to enable ultrasound to compete more effectively with nuclear stress testing, the leading procedure for detecting coronary heart disease. An estimated 10.7 million procedures are done each year in the U.S. to detect coronary heart disease, the leading cause of death in the United States. For more information about Acusphere visit the Company's web site at www.acusphere.com. "Acusphere" is a trademark of Acusphere, Inc.

[calven]

Going to join you tomorrow - APPLAUD! 

[thai626]

Sup Fooseman, excellent post!!  I think we have found our ascending triangle play of the week.  I'll be joining you tomorrow my friend!   

That post definitely deserves an applaud   

Thai

[calven]

In from 6.08 - stop set tight - looks like a possible false breakout...

[fous]

Crash and Burn. Sold this dud 

-fous

[calven]

Down .05 a share- stop limit at 5.70 - we'll see what happens

[thai626]

Crash and Burn. Sold this dud 

-fous

Sold off on low volume................I'm going to give this one a bit longer.  You probably made the smart decision Foose.............only time will tell!

Thai

[fous]

ACUS made a false breakout when i first posted. Price action retesting the neckline once again, Another buying opportunity will arise on a breakout of the neckline at 6.50.

-fous

[sebfr]

If you love ascending triangle, here is one ! 

Good time to buy with few risk...

[setravis]

Changed Ticker Symbol...
ACUS is no longer valid. It has changed to ACUS.PK

[setravis]

ACUS.PK - Volume Alert...

Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and formulations of existing drugs using its proprietary porous microparticle technology in the United States.

[setravis]

Acusphere (ACUS): Amended NDA for Imagify (Perflubutane Polymer Microspheres) for Injectable Suspension as a cardiac imaging agent for the detection of coronary artery disease. Amended indication would be limited to subsets of patients undergoing pharmacologic stress techniques compared to original request for more widespread use with an expected PDUFA decision date of 5/31/09.

52wk Range: 0.02 - 0.83
Volume: 1,778,201
Avg Vol (3m): 395,390

[setravis]

My reasons for owning this stock have not changed. I still like their candidate, Imagify, and I do believe it will be approved.


updated chart look...

[setravis]

updated chart look...



52wk Range: 0.02 - 0.80
Volume: 9,944,557
Avg Vol (3m): 524,325

Technicals
Most Actives
Percentage Gainer

Last Price Quote is:
inf%above 13-day MA
inf%above 50-day MA
RS Rating: 99 

Fundamentals
Earnings Expected on May 11

Key Data:
Market Cap (M): $11.39 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 08/10/2009
Last Analyst Rating: Neutral